StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bausch Health Companies's price to sales ratio was 0.3× on Nov 11, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.2× to 1.2×, with a median of 0.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×+0.0
2025Dec 31, 20250.3×−0.1
2024Dec 31, 20240.3×−0.0
2023Dec 29, 20230.3×+0.1
2022Dec 30, 20220.3×−0.9
2021Dec 31, 20211.2×+0.3
2020Dec 31, 20200.9×−0.3
2019Dec 31, 20191.2×+0.5
2018Dec 31, 20180.8×−0.0
2017Dec 29, 20170.8×+0.3
2016Dec 30, 20160.5×−3.0
2015Dec 31, 20153.5×−2.4
2014Dec 31, 20145.9×−2.5
2013Dec 31, 20138.4×+2.8
2012Dec 31, 20125.6×−0.6
2011Dec 30, 20116.3×−2.9
2010Dec 31, 20109.2×+2.5
2009Dec 31, 20096.7×–

More Bausch Health Companies figures

See a number that looks wrong?